Quantitative Investment Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Quantitative Investment Management’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-54,273	Closed	-$6.21M	–	644
2020 Q3	$6.21M	Buy	54,273 +33,515	+161%	+$3.62M	0.54%	41
2020 Q2	$2.33M	Buy	+20,758	New	+$2.2M	0.24%	100
2020 Q1	–	Sell	-10,320	Closed	-$1.12M	–	892
2019 Q4	$1.12M	Buy	+10,320	New	+$1.1M	0.03%	427
2019 Q3	–	Sell	-21,262	Closed	-$2.78M	–	820
2019 Q2	$2.78M	Buy	21,262 +13,262	+166%	+$1.71M	0.11%	229
2019 Q1	$1.08M	Buy	+8,000	New	+$995K	0.06%	360
2018 Q4	–	Sell	-9,000	Closed	-$1.25M	–	876
2018 Q3	$1.25M	Buy	+9,000	New	+$1.13M	0.04%	265
2017 Q4	–	Sell	-34,300	Closed	-$4.81M	–	922
2017 Q3	$4.81M	Buy	+34,300	New	+$4.66M	0.05%	338
2017 Q1	–	Sell	-5,900	Closed	-$721K	–	979
2016 Q4	$721K	Sell	5,900 -10,000	-63%	-$1.22M	0.02%	651
2016 Q3	$1.95M	Buy	+15,900	New	+$2.05M	0.06%	317
2015 Q4	–	Sell	-35,500	Closed	-$5.55M	–	897
2015 Q3	$5.55M	Sell	35,500 -33,999	-49%	-$6.2M	0.42%	55
2015 Q2	$12.6M	Buy	+69,499	New	+$12M	1.89%	9
2015 Q1	–	Sell	-4,400	Closed	-$814K	–	773
2014 Q4	$814K	Sell	4,400 -1,200	-21%	-$222K	0.13%	171
2014 Q3	$928K	Buy	+5,600	New	+$920K	0.18%	103
2014 Q2	–	Sell	-11,500	Closed	-$1.75M	–	693
2014 Q1	$1.75M	Buy	11,500 +3,000	+35%	+$477K	0.08%	164
2013 Q4	$1.13M	Buy	+8,500	New	+$1.02M	0.11%	181

Other funds holding ALXN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Quantitative Investment Management's ALXN Position: Q4 2020 in Review

Quantitative Investment Management sold out of Alexion Pharmaceuticals (ALXN) in Q4 2020, closing a stake of 54,273 shares — an estimated $6.21M sold.

Quantitative Investment Management first reported a position in ALXN in Q4 2013 and held it in 15 quarters. The position peaked at $12.6M in Q2 2015. 827 funds tracked by Wall St. Rank hold ALXN as of Q4 2020.

Quantitative Investment Management reported no remaining Alexion Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
Quantitative Investment Management sold 54,273 Alexion Pharmaceuticals shares in Q4 2020, an estimated $6.21M.
Quantitative Investment Management first reported a position in Alexion Pharmaceuticals in Q4 2013 and held it in 15 quarters.
Quantitative Investment Management's Alexion Pharmaceuticals position peaked at $12.6M in Q2 2015.
827 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q4 2020.

Based on Quantitative Investment Management's 13F filing for Q4 2020, filed 16 Feb 2021.